Therapeutic Asset Ratings
1,531 results matching 1 filter
91,583 assets · 7,906 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
syh2051
Gastric Cancer
Fujian Cancer Hospital
N/A
D
(30)
syh2051
Digestive System Neoplasm
Fujian Cancer Hospital
N/A
D
(30)
SYNTHETIC LEVOTHYROXINE
Infertility Disorder
Muhamed Ahmed Abdelmoaty Muhamed Alhagrasy
N/A
D
(30)
SYNTHETIC LEVOTHYROXINE
Polycystic Ovary Syndrome
Muhamed Ahmed Abdelmoaty Muhamed Alhagrasy
N/A
D
(30)
sys6010
Gastric Cancer
Fujian Cancer Hospital
N/A
D
(30)
sys6010
Digestive System Neoplasm
Fujian Cancer Hospital
N/A
D
(30)
TACROLIMUS
Autoimmune Disease
Clarteis
N/A
D
(30)
TACROLIMUS
Skin Disorder
Clarteis
N/A
D
(30)
TACROLIMUS
Vitiligo
Xijing Hospital
N/A
D
(30)
Tafolecimab
Ischemic Stroke
Beijing Tiantan Hospital
N/A
D
(30)
Tamsulosin
Prostate Disorder
Menoufia University
N/A
D
(30)
Tamsulosin
Benign Prostatic Hyperplasia
Menoufia University
N/A
D
(30)
Tamsulosin
Prostate Neoplasm
Menoufia University
N/A
D
(30)
Tamsulosin
Urinary System Disorder
Centre Hospitalier Universitaire de Nīmes
N/A
D
(30)
TECHNETIUM TC 99M PENTETATE SODIUM
Renal Cell Carcinoma
NYU Langone Health
N/A
D
(30)
TECHNETIUM TC 99M SESTAMIBI
Breast Neoplasm
Mayo Clinic
N/A
D
(30)
TESTOSTERONE UNDECYLATE
Male Breast Carcinoma
University Medical Center Groningen
N/A
D
(30)
Thalidomide
Gastric Antral Vascular Ectasia
Institute of Liver and Biliary Sciences, India
N/A
D
(30)
Thalidomide
Cirrhosis Of Liver
Institute of Liver and Biliary Sciences, India
N/A
D
(30)
Thalidomide
Thalassemia
Riphah International University
N/A
D
(30)
THIETHYLPERAZINE
Obesity Disorder
IVO JURISIC
N/A
D
(30)
THROCALCITONIN
Neuralgia
Tanta University
N/A
D
(30)
THROCALCITONIN
Spinal Cord Injury
Tanta University
N/A
D
(30)
Ticagrelor
Myocardial Ischemia
Shiraz University of Medical Sciences
N/A
D
(30)
Tinzaparin
Obesity Disorder
University College Dublin
N/A
D
(30)
Showing 1126 to 1150 of 1,531 assets
Previous
Page 46 of 62
Next